Inhibition of invasion and metastasis in oral cancer by targeting urokinase-type plasminogen activator receptor

Oral Oncology

Volumn 41, Issue 10, 2005, Pages 971-977

  Nozaki, Shinichi ^a   Endo, Yoshio ^a   Nakahara, Hirokazu ^b   Yoshizawa, Kunio ^a   Hashiba, Yukari ^a   Kawashiri, Shuichi ^a   Tanaka, Akira ^a   Nakagawa, Kiyomasa ^a   Matsuoka, Yudai ^b   Kogo, Mikihiko ^b   Yamamoto, Etsuhide ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Antisense oligonucleotide; Oral squamous cell carcinoma; Small interfering RNA; Urokinase type plasminogen activator receptor

Indexed keywords

MESSENGER RNA; UROKINASE RECEPTOR;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; METASTASIS; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHICK EMBRYO; HUMANS; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR;

EID: 26444486892     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.05.013     Document Type: Article

References (30)

1. P. Mignatti, and D.B. Rifkin Biology and biochemistry of proteinases in tumor invasion Physiol Rev 73 1 1993 161 195
2. K. Danø, J. Romer, and B.S. Nielsen Cancer invasion and tissue remodeling-cooperation of protease systems and cell types APMIS 107 1 1999 120 127
3. Y. Wang The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis Med Res Rev 21 2 2001 146 170
4. L. Ossowski, G. Clunie, M.T. Masucci, and F. Blasi In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion J Cell Biol 115 4 1991 1107 1112
5. M.J. Duffy, and C. Duggan The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer Clin Biochem 37 7 2004 541 548
6. S. Nozaki, Y. Endo, and S. Chatani Plasminogen activation system associated with invasion and metastasis of head and neck tumor A.K. Varma M. Mori Oral Oncology vol. 4B 1995 Macmillan India Limited New Delhi 145 148
7. E. Yamamoto, G. Kohama, H. Sunakawa, M. Iwai, and H. Hiratsuka Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity Cancer 51 12 1983 2175 2180
8. S. Nozaki, Y. Endo, and S. Kawashiri Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis Oral Oncol 34 1 1998 58 62
9. A. Quattrone, G. Fibbi, and E. Anichini Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression Cancer Res 55 1 1995 90 95
10. A.L. Roldan, M.V. Cubellis, and M.T. Masucci Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis EMBO J 9 2 1990 467 474
11. J.G. Conboy, J. Chan, N. Mohandas, and Y.W. Kan Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells Proc Natl Acad Sci USA 85 23 1988 9062 9065
12. M. Noguchi-Takino, Y. Endo, Y. Yonemura, and T. Sasaki Relationship between expression of plasminogen activator system and metastatic ability in human cancers Int J Oncol 8 1996 97 105
13. S. Kawashiri, S. Kumagai, K. Kojima, H. Harada, and E. Yamamoto Development of a new invasion and metastasis model of human oral squamous cell carcinomas Eur J Cancer B Oral Oncol 31B 4 1995 216 221
14. Y. Endo, T. Sasaki, F. Harada, and M. Noguchi Specific detection of metastasized human tumor cells in embryonic chicks by the polymerase chain reaction Jpn J Cancer Res 81 8 1990 723 726
15. H. Nakahara, M. Nomizu, S.K. Akiyama, Y. Yamada, Y. Yeh, and W.T. Chen A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides J Biol Chem 271 44 1996 27221 27224
16. H. Nakahara, L. Howard, and E.W. Thompson Transmembrane/cytoplasmic domain-mediated membrane type1-matrix metalloprotease docking to invadopodia is required for cell invasion Proc Natl Acad Sci USA 94 15 1997 7959 7964
17. J.A. Aguirre-Ghiso, K. Kovalski, and L. Ossowski Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J Cell Biol 147 1 1999 89 104
18. J.A. Aguirre-Ghiso, D. Liu, A. Mignatti, K. Kovalski, and L. Ossowski Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo Mol Biol Cell 12 4 2001 863 879
19. C.W. Crowley, R.L. Cohen, B.K. Lucas, G. Liu, M.A. Shuman, and A.D. Levinson Prevention of metastasis by inhibition of the urokinase receptor Proc Natl Acad Sci USA 90 11 1993 5021 5025
20. H.Y. Min, L.V. Doyle, and C.R. Vitt Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice Cancer Res 56 10 1996 2428 2433
21. F. Margheri, S. D'Alessio, and S. Serrati Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases Gene Ther 12 8 2005 702 714
22. C.S. Gondi, S.S. Lakka, D.H. Dinh, W.C. Olivero, M. Gujrati, and J.S. Rao RNAi-mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumor growth in gliomas Oncogene 23 52 2004 8486 8496
23. J. Romer, B.S. Nielsen, and M. Ploug The urokinase receptor as a potential target in cancer therapy Curr Pharm Des 10 19 2004 2359 2376
24. U. Novak, B.G. Cocks, and J.A. Hamilton A labile repressor acts through the NFκB-like binding sites of the human urokinase gene Nucleic Acids Res 19 12 1991 3389 3393
25. M.P. Vincenti, C.I. Coon, and C.E. Brinckerhoff Nuclear factor κB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1β-stimulated synovial fibroblasts Arthritis Rheum 41 11 1998 1987 1994
26. C. He Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter Cancer Lett 106 2 1996 185 191
27. N.M. Patel, S. Nozaki, and N.H. Shortle Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide Oncogene 19 36 2000 4159 4169
28. S. Nozaki, G.W. Sledge Jr., and H. Nakshatri Repression of GADD153/CHOP by NF-κB: a possible cellular defense against endoplasmic reticulum stress-induced cell death Oncogene 20 17 2001 2178 2185
29. T. Shiratsuchi, H. Ishibashi, and K. Shirasuna Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines J Cell Physiol 193 3 2002 340 348
30. S. Hapke, M. Gawaz, and K. Dehne β3A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter Mol Cell Biol 21 6 2001 2118 2132